Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Redhill Biopharma Ltd (RDHL)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Redhill ADR's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.427 +0.042    +10.77%
16:00:00 - Closed. Currency in USD ( Disclaimer )
After Hours
0.420
-0.007
-1.639%
19:54:14 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 658,491
  • Bid/Ask: 0.401 / 0.420
  • Day's Range: 0.390 - 0.438
Redhill ADR 0.427 +0.042 +10.77%

Redhill Biopharma Ltd Company Profile

 
Get an in-depth profile of Redhill Biopharma Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

113

Equity Type

ADR

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers’ diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in Phase 2 study to treat advanced unresectable cholangiocarcinoma, and in investigator-sponsored Phase 2 study to treat prostate cancer; RHB-107, which is in Phase 2/3 study to treat outpatients infected with COVID-19 disease, and preclinical evaluation study to treat advanced unresectable cholangiocarcinoma, as well as has completed Phase 2 study to treat gastrointestinal and other solid tumors; and RHB-104, which is in Phase 3 studies for Crohn's disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis. RedHill Biopharma Ltd. was incorporated in 2009 and is headquartered in Tel Aviv, Israel.

Contact Information

Address 21 Ha’arba’a Street
Tel Aviv, 6473921
Israel
Phone 972 3 541 3131
Fax 972 3 541 3144

Top Executives

Name Age Since Title
Alessandro E. Della Cha 58 2021 Independent Director
Ira N. Kalfus 61 2010 Member of Advisory Board
Shmuel Cabilly 72 2019 Independent Director
Werner Tschollar - - Member of Advisory Board
Ran Oren - - Member of Advisory Board
Thomas Julius Borody - - Member of Advisory Board
Yechezkel Barenholz - - Member of Advisory Board
Jerry Rosenblatt - - Member of Advisory Board
Kenneth Reed 68 2009 Independent Director
Abe Schwartz - - Member of Advisory Board
Matthew Scott Harris 70 2017 Member of Advisory Board
Alla Felder 50 2019 Independent Director
Ofer Tsimchi 65 2011 Independent Director
Eric Swenden 80 2010 Independent Director
Dror Ben-Asher 58 2009 Co-Founder, Chairman & CEO
Rick D. Scruggs 64 2016 Chief Commercial Officer, President of RedHill Biopharma Inc. & Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RDHL Comments

Write your thoughts about Redhill Biopharma Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
laurent Eliane
laurent Eliane Apr 04, 2023 3:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Great company. just now print more share in order to fund you abilities
dallas dallas
dallas dallas Apr 04, 2023 3:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
tool
laurent Eliane
laurent Eliane Apr 03, 2023 10:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
short seller, they are smart enough to make another reverse split...ahahsha
laurent Eliane
laurent Eliane Mar 27, 2023 2:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
make another split reverse in order to give more to short seller
laurent Eliane
laurent Eliane Mar 27, 2023 2:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
make another reverse spli in order to give more opportunités for short sellers
laurent Eliane
laurent Eliane Mar 27, 2023 2:33PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Great, do you think the management see the disaster of what they are doing ?...
laurent Eliane
laurent Eliane Dec 28, 2022 5:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wouahhh, what happened...!!..after 60 days going down...it just went up ....! really amazing...
laurent Eliane
laurent Eliane Dec 20, 2022 3:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think à bunch of short seller has made or think they still can make money. they did not close their position yet...and this day is closerie than you think. it will rocket till 0.65
Paolo Rebiertis
Paolo Rebiertis Jun 14, 2022 2:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
0.685 but is a joke? 3 drugs on market and less than 40 ml cap??? Please some big company buy this and use their drugs to make money
rocket printer
rocketer Mar 13, 2022 9:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1.73$ .... management need to go. Shareholder value destroyed.
Scott Ornelas
Jatslo Oct 20, 2021 3:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
RDHL (P) 0.00000000 5.51000000
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email